All Stories

  1. Rapid-response RNA-fluorescence in situ hybridization (FISH) assay platform for coronavirus antiviral high-throughput screening
  2. SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection
  3. Vaccination Decreases the Infectious Viral Load of Delta Variant SARS-CoV-2 in Asymptomatic Patients
  4. QTQTN motif upstream of the furin-cleavage site plays a key role in SARS-CoV-2 infection and pathogenesis
  5. Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis
  6. Mouse-adapted SARS-CoV-2 protects animals from lethal SARS-CoV challenge
  7. Binding and entering: COVID finds a new home
  8. Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
  9. Engineering SARS-CoV-2 using a reverse genetic system
  10. Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape
  11. Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
  12. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV.
  13. Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response
  14. Novel Ionophores Active against La Crosse Virus Identified through Rapid Antiviral Screening
  15. SARS-CoV-2 is sensitive to type I interferon pretreatment
  16. Return of the Coronavirus: 2019-nCoV
  17. Novel ionophores active against La Crosse virus identified through rapid antiviral screening
  18. Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection
  19. Peptidoglycan-Associated Cyclic Lipopeptide Disrupts Viral Infectivity
  20. Peptidoglycan associated cyclic lipopeptide disrupts viral infectivity
  21. Shortening of Zika virus CD-loop reduces neurovirulence while preserving antigenicity
  22. Middle East Respiratory Syndrome Vaccine Candidates: Cautious Optimism
  23. SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus)
  24. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
  25. Combination Attenuation Offers Strategy for Live Attenuated Coronavirus Vaccines
  26. CC002/Unc females are mouse models of exercise-induced paradoxical fat response
  27. Combination attenuation offers strategy for live-attenuated coronavirus vaccines
  28. Viral metagenomics, protein structure, and reverse genetics: Key strategies for investigating coronaviruses
  29. Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform
  30. MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape
  31. Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis
  32. CD-loop Extension in Zika Virus Envelope Protein Key for Stability and Pathogenesis
  33. MERS Accessory ORFs Key for Pathogenesis
  34. MERS-CoV NSP16 necessary for IFN resistance and viral pathogenesis
  35. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
  36. Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice
  37. Jumping species—a mechanism for coronavirus persistence and survival
  38. Epitope Addition and Ablation via Manipulation of a Dengue Virus Serotype 1 Infectious Clone
  39. Erratum: Corrigendum: A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
  40. SARS-like WIV1-CoV poised for human emergence
  41. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence
  42. Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross
  43. MERS Vaccine Candidate Offers Promise, but Questions Remain
  44. New Metrics for Evaluating Viral Respiratory Pathogenesis
  45. Coronavirus non-structural protein 16: Evasion, attenuation, and possible treatments
  46. A comprehensive collection of systems biology data characterizing the host response to viral infection
  47. Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses
  48. A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat Coronavirus Strain HKU5 Variant
  49. Attenuation and Restoration of Severe Acute Respiratory Syndrome Coronavirus Mutant Lacking 2'-O-Methyltransferase Activity
  50. Cytokine systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates
  51. Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses
  52. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
  53. Bugs in the system
  54. Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
  55. Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus
  56. Release of Severe Acute Respiratory Syndrome Coronavirus Nuclear Import Block Enhances Host Transcription in Human Lung Cells
  57. Corneal Replication Is an Interferon Response-Independent Bottleneck for Virulence of Herpes Simplex Virus 1 in the Absence of Virion Host Shutoff
  58. Interferon Regulatory Factor 3-Dependent Pathways Are Critical for Control of Herpes Simplex Virus Type 1 Central Nervous System Infection
  59. Control of Herpes Simplex Virus Replication Is Mediated through an Interferon Regulatory Factor 3-Dependent Pathway
  60. Herpes Simplex Virus Virion Host Shutoff Attenuates Establishment of the Antiviral State